Iovance Biotherapeutics
Mariam Mirgoli has a wealth of experience in data management and clinical research spanning various companies such as Gilead Sciences, Abbott Vascular, and Nuvelo. With a background in Physics from California State Polytechnic University-Pomona, Mariam has held leadership positions in data management departments and has been involved in the implementation of electronic data capture systems. Currently serving as the Senior Vice President of Data Management and Solutions at Iovance Biotherapeutics, Mariam has a strong track record in managing clinical data and supporting IT systems in the clinical development environment.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.